Recent Articles
Posted By: Krystle G. Correll
Tue Sep 22nd, 2020
This free two-day public webinar hosted by FDA will be presented by multiple regulatory and industry members from around the world that are members of the International Council for Harmonisation (ICH) E14/S7B Implementation Working Group
Posted By: Krystle G. Correll
Fri Jul 19th, 2019
FDA Public Workshops of Interest: Biomarkers of Neurotoxicity on July 23 & Implementing FDA's Predictive Toxicology Roadmap on September 18
Posted By: Krystle G. Correll
Mon Mar 4th, 2019
You are invited to attend an FDA public workshop planned for March 29, 2019 titled Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities. Registration required by March 27.
Posted By: Krystle G. Correll
Thu Aug 9th, 2018
The Food and Drug Administration is announcing the following public workshop entitled "Regulatory Perspectives on Otic and Vestibular Toxicity: Challenges in Translating Animal Studies to Human Risk Assessment.”
Posted By: Krystle G. Correll
Mon Jun 25th, 2018
Staff Fellow, In Vivo Research Position - U.S. FDA
Silver Spring, Maryland, USA
